The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).
 
Peter Michael Ellis
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Pfizer
Other Relationship - Celgene; Mylan
 
Lisa Durocher-Allen
No Relationships to Disclose
 
Emily Vella
No Relationships to Disclose
 
Alexander Sun
No Relationships to Disclose
 
Yee Ung
Honoraria - Celgene
 
Kevin Ramchandar
No Relationships to Disclose
 
Gail Elizabeth Darling
No Relationships to Disclose
 
John R. Goffin
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca